Condition
Fasciitis
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed2
Terminated1
Not Yet Recruiting1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07471035Not ApplicableNot Yet Recruiting
Focused Shockwave Therapy for Plantar Fasciopathy
NCT04111497Phase 1Terminated
Glasdegib for Chronic Graft-Versus-Host Disease
NCT00441961Not ApplicableCompletedPrimary
Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis
NCT01363375UnknownPrimary
Effects of Different Foot Structures on Plantar Fasciitis and Therapeutic Footwear Intervention
NCT00382941Not ApplicableCompleted
Study of LED Phototherapy for Musculoligamentous Lesions
Showing all 5 trials